Objective To investigate the efficacy of lower cervical spine fracture and dislocation treated by Halo-vest reduction combined with anterior decompression and internal fixation.Methods From January 2009 to December 2012,26 cases of lower cervical spine fracture and dislocation underwent Halovest reduction combined with anterior decompression and internal fixation.There were 18 males and 8 females,aged 19-64 years (mean,42.1 years).Injury resulted from traffic crashes in 11 cases,high falls in 9,and hit by heavy objects in 6.Segment of injury was C5/6in 10 cases,C6/7in 9,C3/4in 4,and C4/5in 3.Prior to anterior decompression/internal fixation and fusion,the Halo-vest external fixation was performed.Neurological performance was evaluated after operation.Results All the patients were followed up for 24-36 months (mean,27.4 months).According to the X-ray films and CT scan at the final follow-up,the alignment of the cervical spine was maintained and the implanted bone was completely fused without internal fixation breaking or loosening.Preoperative neurological status according to the Frankel grading was grade A in 6 cases,grade B in 8,grade C in 7,and grade E in 2.After operation,there were 5 cases in grade A,3 in grade B,4 in grade C,5 in grade D,and 9 in grade E.All together,6 cases presented two-grade improvement in neurological status,13 one-grade improvement,and 5 no changes (P ＜ 0.05).Conclusion Halo-vest reduction combined with anterior decompression and internal fixation is safe and effective in treatment of lower cervical spine fracture and dislocation.

Objective To investigate the percentages of Th17 and CD4+CD25+FoxP3+ regulatory T(Tr) cells and the levels of related cytokines IL-6,IL-23,IL-17 and TGF-β in serum of patients with anlylosing spondylitis(AS).Methods Forty patients with AS and 37 age-matched healthy donors were studied.Flow cytometry Was used to analyze the percentages of blood Th17 and CD4+CD25+FoxP3+Tr cells.The levels of serum IL-6,IL-23,IL-17 and TGF-β were assayed by enzyme-linked immunosorbent assay ( ELISA).Results The proportion of Th17 cells in AS group was significantly higher than those in normal group [ (1.02±0.34)％ vs (0.68±0.29)％,P＜0.05) ],and the proportion of CD4+CD25+FoxP3+ cells was lower in AS group comparing with normal group [(3.77±0.81)％ vs (4.69±1.23)％,P＜0.05)].Meanwhile,serum levels of IL-6,IL-23 and IL-17 were significantly higher in AS group than those in normal group [ (6,15±2.71) ng/L vs (3.31±1.65) ng/L; (9.44±3.12) ng/ml vs (5.82±2.61) ng/ml;(10.53±4.97) ng/L vs (6.78±3.26) ng/L,all P＜0.01 ].In contrast,TGF-β level was decreased in AS group compares with the normal group [ ( 4.76±2.15) ng/ml vs (5.16±2.02) ng/ml,P＞0.05 ],but the difference was not significant.No associations of serum eytokine levels with clinical and laboratory parameters were found in AS.Conclusion The abnormality Th17 cells and Tr cells and their related cytokines IL-6,IL-23,IL-17 and TGF-β changes in patients with AS,which may be involved in immunological pathogenesis of AS.

Objective: To observe the expression of retinal proteins in experimental autoimmune uveitis (EAU) mice and to explore the possible molecular mechanism of autoimmune uveitis. Methods: Twelve female C57BL/6J mice were randomly divided into model group and normal control group, 6 mice in each group.In the model group, the EAU model was established by subcutaneous injection of human interphotoreceptor retinoid-binding protein (IRBP) 651-670.The fundal change of EAV mice was assessed by direct ophthalmoscope, OCT and histopathological staining.At 18 days after immunization, the retinas of the two groups were taken for retinal protein extraction, protein restriction enzyme digestion, mass spectrometry detection, data analysis, and bioinformatics analysis.This study was approved by the experimental animal Ethics Committee of Tianjin Medical University Eye Hospital (TJYY2018070113). The feeding and use of experimental animals follow the ARVO statement. Results: The EAU mouse model was successfully established.At 10 days after immunitation, the retina of EAV mouse was damaged.At 18 days after immunization, retinal edema and infiltration of inflammatory cells into vitreous were observed.Proteomic results showed that a total of 4 458 proteins were identified in this study, of which 522 were differentially-expressed proteins (fold change>1.5, P<0.05). Among these differentially-expressed proteins, 147 proteins including Stat1 and Stat3 were up-regulated and 375 proteins including Gucy2f and Rho were down-regulated.These differentially-expressed proteins were closely related to platelet activation, integrin signaling, T cell activation, the phototransduction cascade, Toll-like receptor and so on. Conclusions EAU is related to the abnormal expression of Stat1, Stat3 and other proteins, as well as the abnormal regulation of platelet activation and integrin signal pathway.

AIM:To compare the efficacy of 0.01% and 0.05% atropine eye drops in controlling myopia in adolescents.METHODS:A total of 108 adolescents with myopia admitted to our hospital from October 2021 to February 2023 were selected and randomly divided into 54 cases each in the observation group and the control group. All patients wore full-corrected monofocal frame glasses for the correction of refractive error. Patients in the control group used 0.01% atropine eye drops, and patients in the observation group used 0.05% atropine eye drops. The changes of the axial length(AL), pupil diameter, spherical equivalent(SE), amplitude of accommodation, as well as the occurrence of discomfort symptoms were compared between the two groups of patients before treatment and at 4 and 12 mo after treatment.RESULTS: Compared with the pre-treatment period, the AL and pupil diameter of both groups increased, and the SE and amplitude of accommodation decreased after treatment(all P<0.05). The AL of the observation group was smaller than that of the control group, and the pupil diameter and SE were larger than that of the control group after treatment(all P<0.05). At the beginning of medication, 6 eyes(11.8%)in the control group and 15 eyes(28.8%)in the observation group showed photophobia(outdoor bright light), and 2 eyes in the observation group showed blurred vision, and there was a difference in the comparison of the discomfort symptoms between the two groups(χ2=6.502, P=0.011).CONCLUSION:0.05% atropine eye drops are more effective in controlling myopia in adolescents, but have a greater influence on pupil diameter and a higher risk of discomfort.

AIM:To compare the efficacy of 0.01% and 0.05% atropine eye drops in controlling myopia in adolescents.METHODS:A total of 108 adolescents with myopia admitted to our hospital from October 2021 to February 2023 were selected and randomly divided into 54 cases each in the observation group and the control group. All patients wore full-corrected monofocal frame glasses for the correction of refractive error. Patients in the control group used 0.01% atropine eye drops, and patients in the observation group used 0.05% atropine eye drops. The changes of the axial length(AL), pupil diameter, spherical equivalent(SE), amplitude of accommodation, as well as the occurrence of discomfort symptoms were compared between the two groups of patients before treatment and at 4 and 12 mo after treatment.RESULTS: Compared with the pre-treatment period, the AL and pupil diameter of both groups increased, and the SE and amplitude of accommodation decreased after treatment(all P<0.05). The AL of the observation group was smaller than that of the control group, and the pupil diameter and SE were larger than that of the control group after treatment(all P<0.05). At the beginning of medication, 6 eyes(11.8%)in the control group and 15 eyes(28.8%)in the observation group showed photophobia(outdoor bright light), and 2 eyes in the observation group showed blurred vision, and there was a difference in the comparison of the discomfort symptoms between the two groups(χ2=6.502, P=0.011).CONCLUSION:0.05% atropine eye drops are more effective in controlling myopia in adolescents, but have a greater influence on pupil diameter and a higher risk of discomfort.

Objective To investigate the effect of docosahexaenoic acid(DHA)on human colon cancer cell line HT-29 and underlying mechanism.Methods Human colon cancer cell line HT-29 was incubated with DMSO(control),DHA(25,50,100 μmol/L)and 100 μmol/L DHA and/or 30 μmol/L 740Y-P.Proliferation was examined by MITT;apoptosis was detected by annexin V-FITC/PI.Western blot was used for detection of protein expression of Bcl-2,Bax apoptosis-related protein and PI3K/Akt/mTOR pathway,and RT-qPCR was used for checking mRNA expression of NLRP3/Caspase-1/IL-1β pathway.Results Compared with the control group,DHA 25,50,and 100 μmol/L treatment of HT-29 cells resulted in decreased cell survival(P＜0.05),increased apoptosis(P＜0.05),decreased Bcl-2/Bax ratio(P＜0.05)and decreased phosphorylation of PI3K,Akt and mTOR in HT-29 cells(P＜0.05 or P＜0.01).Expressions of NLRP3,Caspase-1 and IL-1 β mRNA were decreased(P＜0.05).In addition,cell viability,protein phos-phorylation(p-PI3K,p-Akt,p-mTOR)and relative mRNA expression of NLRP3,Caspase 1,and IL-1β were lower in HT-29 cells which were co-incubated with DHA 100 μmol/L and 740Y-P 30 μmol/L than those in the control group(P＜0.05 or P＜0.01)and 740Y-P 30 μmol/L group(P＜0.05),while higher than that of DHA 100 μmol/L group(P＜0.05 or P＜0.01).Conclusions DHA inhibits the proliferation of human colon cancer cell line HT-29,its mecha-nism is potentially related to the inhibition of PI3K/Akt/mTOR and NLRP3/Caspase-1/IL-1 β signaling pathways.

Objective:To explore the therapeutic effect of anti-interleukin (IL)-12/IL-23 p40 antibody on experimental autoimmune uveitis (EAU) and its mechanism.Methods:Sixty-six SPF female C57BL/6N mice aged 6-8 weeks were selected.EAU model was established in 24 mice through immunization with the interphotoreceptor retinoid-binding protein (IRBP) 651-670.The 24 mice were sacrificed before immunization, and on the 3rd, 12th, and 18th day after immunization, with 6 at each time point.Flow cytometry was used to detect the proportion of IL-17A + interferon-γ (IFN-γ) + CD4 + T cells in the spleen, lymph nodes and eyeballs.Another 6 mice were selected to establish EAU model, and fundus images of the mice were taken with a small animal imaging instrument and optical coherence tomography (OCT) 18 days after immunization.The 6 mice were sacrificed after OCT examination and the eyeballs were collected.Hematoxylin-eosin staining was used to observe the retinal inflammation and morphological changes in tissue structure.Flow cytometry was employed to detect the proportion of IL-17A + IFN-γ + CD4 + T cells in lymph nodes.The 6 mice were divided into IL-17A + IFN-γ + highly expressed group and IL-17A + IFN-γ + lowly expressed group according to flow cytometry results, and the retinal injury was compared between the two groups.EAU model was established in another 36 mice, which were divided into anti-IL-12/IL-23 p40 group and IgG group by random number table method, with 18 mice in each group.Anti-IL-12/IL-23 p40 or IgG was injected by tail vein at a 3-day inteval according to grouping.On the 12th and 18th day after immunization, 6 mice were selected from each group to collect lymph nodes and eyeballs, and the proportion of T cell subsets was detected by flow cytometry.Eyeballs of 6 mice in each group were extracted on the 24th day after immunization and retinal damage was observed by hematoxylin-eosin staining.The induced differentiation of CD4 + T cells in vitro was assayed by flow cytometry.The expressions of IL-17 and IFN-γ were detected by enzyme-linked immunosorbent assay (ELISA) after induced differentiation of IL-17A + IFN-γ + CD4 + T cells.The relative expression levels of Th1 transcription factor T-bet and Th17 transcription factor retinoid acid-related orphan nuclear receptor γt (ROR-γt) after induced differentiation of IL-17A + IFN-γ + CD4 + T cells were detected by real-time quantitative PCR.The use and care of animals followed the ARVO statement and this study protocol was approved by an Ethics Committee of Experimental Animals of Tianjin Medical University Eye Hospital (No.TJYY2019111019). Results:There were significant differences in the proportion of IL-17A + IFN-γ + CD4 + T cells in lymph nodes, spleen and eyeballs between wild-type mice and EAU mice at the 3rd, 12th and 18th day after immunization ( H=9.642, 16.531, 10.385; all at P<0.05). Compared with before immunization, the proportion of IL-17A + IFN-γ + CD4 + T cells was significantly increased in lymph nodes of EAU mice on the 12th day following immunization and was significantly increased in spleen and lymph nodes on day 18 after immunization (all at P<0.05). Severe retinal exudation, retinal detachment, severe inflammatory cell infiltration and extensive retinal folds were detected in IL-17A + IFN-γ + highly expressed mice.Mild retinal edema, focal inflammatory cell infiltration and mild retinal folds were found in IL-17A + IFN-γ + lowly expressed mice.The proportion of CD3 and IL-17A + IFN-γ + CD4 + T cells in the eyeballs of anti-IL-12/IL-23 p40 group was lower than that in IgG group at the 18th day after immunization, and the differences were statistically significant ( t=15.304, 8.080; both at P<0.05). On day 12 after immunization, the percentage of IL-17A + IFN-γ + CD4 + T cells in anti-IL-12/IL-23 p40 group was (0.33±0.18)%, which was significantly lower than (4.83±0.45)% in IgG group ( t=15.974, P<0.001). Compared with IgG group, the percentage of Th1, Th17, IL-17A + IFN-γ + CD4 + T cells and the expression levels of IL-17, IFN-γ, T-bet, ROR-γt in anti-IL-12/IL-23 p40 group were significantly decreased, with statistical significances (all at P<0.05). Conclusions:Anti-IL-12/IL-23 p40 has a therapeutic effect on EAU by inhibiting IL-17A + IFN-γ + CD4 + T cells.